Provider

OhanaHealth, a health tech job placement company, today announced its new platform OhanaConnect to connect candidates with companies.

This marks the first automated delivery system that can be used for children 2 to 6. 

Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.

Masimo's O3 Regional Oximeter can be integrated with its SedLine brain function monitor or its Root patient monitoring and connectivity platform. 

The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.

More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.

Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.

Also, health tech investments in Dubai and India explored.  

While on average participants lowered their anxiety and depression, a fraction of the original participants filled in the 9-month follow up. 

In a partnership announced this week, IrisVision and Seva Foundation plan to develop new technology to treat vision impairment and prevent blindness in underserved regions of the globe.